These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 5596893

  • 1. [Allopurinol].
    Scott JT.
    Schweiz Med Wochenschr; 1967 Dec 09; 97(49):1659-62. PubMed ID: 5596893
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of allopurinol on the metabolism of uric acid].
    Swiderska-Kulikowa B, Jelińska S.
    Pol Arch Med Wewn; 1973 Apr 09; 50(4):391-8. PubMed ID: 4574007
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Our experience in the treatment of hyperuricemia with a xanthine oxidase inhibitor (HPP), Allopurinol].
    Rapado Errazti A.
    Rev Esp Reum Enferm Osteoartic; 1966 Oct 09; 11(8):304-6. PubMed ID: 5997999
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment with allopurinol in gout and hyperuricemic renal disease].
    Hood B, Olander R.
    Lakartidningen; 1973 Mar 28; 70(13):1297-300. PubMed ID: 4699017
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Allopurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A, Nardini A, Busonera G.
    Clin Ter; 1968 Apr 30; 45(2):141-54. PubMed ID: 5736585
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F, Saporta L, de Géry A, Jabre E.
    Rev Rhum Mal Osteoartic; 1970 Apr 30; 37(6):443-50. PubMed ID: 5453852
    [No Abstract] [Full Text] [Related]

  • 13. [Allopurinol: its clinical use].
    Zucchelli P, Sasdelli M, Fusaroli M.
    G Clin Med; 1968 Oct 30; 49(10):1014-37. PubMed ID: 5735670
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of daily single doses of 300 mg allopurinol on serum uric acid concentration and urate excretion in gouty patients (author's transl)].
    Matzkies F, Berg G.
    Dtsch Med Wochenschr; 1974 Nov 29; 99(48):2464-5. PubMed ID: 4448143
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Allpurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A, Nardini A, Busonera G.
    Rev Clin Esp; 1969 Mar 31; 112(6):141-54. PubMed ID: 5347028
    [No Abstract] [Full Text] [Related]

  • 17. Depletion of erythrocyte phosphoribosylpyrophosphate in man.
    Fox IH, Wyngaarden JB, Kelley WN.
    N Engl J Med; 1970 Nov 26; 283(22):1177-82. PubMed ID: 4319625
    [No Abstract] [Full Text] [Related]

  • 18. Basic sciences in medicine: the example of gout.
    Stetten D.
    N Engl J Med; 1968 Jun 13; 278(24):1333-6. PubMed ID: 5648600
    [No Abstract] [Full Text] [Related]

  • 19. Gout management: let's get it right this time.
    Sundy JS.
    Arthritis Rheum; 2008 Nov 15; 59(11):1535-7. PubMed ID: 18975368
    [No Abstract] [Full Text] [Related]

  • 20. Febuxostat versus allopurinol for gout.
    Gelber AC.
    N Engl J Med; 2006 Apr 06; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.